In order to study differences in mortality and causes of death between HIV positive and HIV negative intravenous drug users (IVDU), 1009 (180 HIV positive and 829 HIV negative) IVDU in Oslo, Norway, were followed from their first HIV test for a mean period of 36 months (range 1-67 months).
Eighty-seven (55 HIV negatives and 32 HIV positives) died during the follow-up period.
The risk of death for IVDU was 31 times higher than for the general population.
The estimated probability of survival after 3 years of follow-up was 0.92 for the whole cohort, 0.93 for the HIV negative group and 0.87 for the HIV positive group (P<0.001, log rank test).
Mots-clés Pascal : Immunodéficit acquis syndrome, Virose, Infection, Toxicomanie, Mortalité, Immunopathologie, Hémopathie, Voie intraveineuse, Epidémiologie, Cause, Séropositivité, Norvège, Europe, Homme, Etude longitudinale
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Drug addiction, Mortality, Immunopathology, Hemopathy, Intravenous administration, Epidemiology, Cause, Seropositivity, Norway, Europe, Human, Follow up study
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0395612
Code Inist : 002B06D01. Création : 199406.